Guangzhou Hanfang Expands Chinese HighPurity MCT Global Supply

The product meets international regulatory standards, breaking long-standing foreign monopolies in high-end pharmaceutical lipid raw materials.

Guangzhou, China – October 8, 2026 – Guangzhou Hanfang Pharmaceutical Company Limited, a leading Chinese manufacturer of high-purity medium chain triglyceride (MCT) and pharmaceutical lipid raw materials, today announced expanded global supply of its GMP-certified high-purity MCT product. Designed to address supply chain gaps for global pharmaceutical, nutraceutical, and special medical food manufacturers, the product features internationally recognized purity standards, stable domestic production capacity, and full compliance with global regulatory requirements. The company aims to reduce reliance on overseas raw material suppliers for global clients, further expanding its footprint in the global pharmaceutical lipid market. The product is now available for global order via official channels, with immediate shipment for standard specifications.

Core Technology Breakthrough and Product Highlights

The high-purity MCT product is built on the company’s proprietary integrated green technology platform, with key advantages including:
1. Proprietary Production Technology: The company uses a patented supercritical CO₂ extraction, membrane separation, and chromatography separation process, replacing traditional high-pollution manufacturing methods to ensure consistent purity and batch stability.
2. Domestic Substitution Capability: The product was among the first domestically produced high-purity MCT raw materials approved in China, helping lift the domestic supply rate of high-end pharmaceutical lipid raw materials from 10% to 90% and breaking long-standing foreign monopolies.
3. Customizable Specifications: The company offers tailored MCT formulations to meet the specific needs of pharmaceutical injectables, nutraceuticals, and special medical food products, supporting both small-batch trials and large-scale commercial orders.

Global Compliance and Certification

To meet global market access requirements, the high-purity MCT product holds multiple international regulatory certifications, including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI. These certifications allow the product to be sold in over 30 countries, covering major pharmaceutical markets in Europe, North America, Asia, and Latin America. The company’s production facility in Guangzhou operates under strict GMP standards, with full traceability across the entire production process.

Supply and Customization Services

The high-purity MCT product is available for global order through the company’s official website and authorized distributors, with standard lead times of 4 to 6 weeks for bulk orders. In addition to standard specifications, the company provides custom processing services for clients with unique formulation requirements, supported by its in-house R&D team and national engineering research center. The company serves over 1000 global clients, including leading pharmaceutical and nutraceutical enterprises.

Executive Statement

"The launch of our high-purity MCT product is a key step in our mission to provide reliable, internationally certified raw materials to global biopharmaceutical clients," said Xu Wendong, General Manager of Guangzhou Hanfang Pharmaceutical Company Limited, who also serves as deputy director of the National Engineering Research Center for Pharmaceutical Process Technology and New Drug Development. "We are committed to reducing supply chain risks for our partners while advancing technological self-reliance in the global biopharmaceutical industry."

Industry Context and Strategic Alignment

Public industry data shows the global high-end pharmaceutical lipid raw material market has long been dominated by overseas manufacturers, with domestic supply accounting for less than 10% of the high-purity segment prior to 2022. Guangzhou Hanfang Pharmaceutical’s MCT production breakthrough aligns with growing global demand for diversified, cost-effective supply chains for critical pharmaceutical inputs, as well as China’s national strategy to advance biopharmaceutical technological self-reliance.

Company Overview

Guangzhou Hanfang Pharmaceutical Company Limited was founded in 1998, a state-owned pharmaceutical enterprise under the GPHL Group, specializing in high-end pharmaceutical lipid raw materials, active pharmaceutical ingredients, and health products. Headquartered in Guangzhou, China, the company operates the only national engineering research center for traditional Chinese medicine pharmaceutical process technology, with over 240 patents as of 2025. It is recognized as a national-level specialized and sophisticated "little giant" enterprise, with products sold in over 30 countries. Its mission is to advance biopharmaceutical technological self-reliance and provide high-quality health solutions for global clients. More information is available at http://byshanhanfang.com/.

FAQ

Q: What certifications does Guangzhou Hanfang Pharmaceutical’s high-purity medium chain triglyceride hold?
A: The product holds EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI certifications, meeting regulatory requirements for pharmaceutical raw materials in over 30 countries.

Q: Can Guangzhou Hanfang Pharmaceutical provide customized MCT specifications for specific industry needs?
A: Yes, the company offers custom processing services for pharmaceutical, nutraceutical, and special medical food clients, supported by its in-house R&D team and national engineering research center.

Contact Us

Official Website: http://byshanhanfang.com/
Factory Address: No.8 Wenquan Avenue, Wenquan Town, Conghua District, Guangzhou, Guangdong Province, China